George A. Kegler
CIK 1761753 · EVP & CFO, Interim · last filed 2026-06-03
George A. Kegler is an EVP & CFO, Interim who has filed 6 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for ENVB, was dated Jun 3, 2026. Current disclosed insider exposure totals $40.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$40.4K
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENVB | Director | 26,418 | $1.53 | $40.4K | $0 | 4 | 2026-06-03 |
| Keenova Therapeutics plc (MNK) Delisted | EVP & CFO, Interim | 14,985 | $0.34 | $5.1K | $0 | 2 | 2019-01-11 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | ENVB | Grant (A) | +18,518 | $0 | EDGAR |
| 2025-12-30 | ENVB | Grant (A) | +7,633 | $0 | EDGAR |
| 2024-10-11 | ENVB | Grant (A) | +47,733 | $0 | EDGAR |
| 2021-02-17 | ENVB | Grant (A) | +15,957 | $0 | EDGAR |
| 2019-01-11 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −81 | -$1.6K | EDGAR |
| 2019-01-07 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −249 | -$4.1K | EDGAR |